中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/02/02 | 3,310 | 3,320 | 3,271 | 3,296 | -29 | -0.9% | 2,377,400 |
| 2023/02/01 | 3,321 | 3,368 | 3,319 | 3,325 | -33 | -1% | 2,220,000 |
| 2023/01/31 | 3,370 | 3,391 | 3,349 | 3,358 | -34 | -1% | 1,731,900 |
| 2023/01/30 | 3,425 | 3,434 | 3,383 | 3,392 | -52 | -1.5% | 1,919,400 |
| 2023/01/27 | 3,499 | 3,509 | 3,440 | 3,444 | -42 | -1.2% | 1,726,100 |
| 2023/01/26 | 3,488 | 3,504 | 3,465 | 3,486 | +23 | +0.7% | 2,052,200 |
| 2023/01/25 | 3,420 | 3,480 | 3,416 | 3,463 | +34 | +1% | 1,742,100 |
| 2023/01/24 | 3,446 | 3,455 | 3,393 | 3,429 | +37 | +1.1% | 2,047,600 |
| 2023/01/23 | 3,370 | 3,404 | 3,355 | 3,392 | +40 | +1.2% | 1,713,100 |
| 2023/01/20 | 3,330 | 3,353 | 3,317 | 3,352 | +8 | +0.2% | 1,649,200 |
| 2023/01/19 | 3,335 | 3,362 | 3,316 | 3,344 | -40 | -1.2% | 2,042,600 |
| 2023/01/18 | 3,255 | 3,390 | 3,251 | 3,384 | +169 | +5.3% | 2,953,300 |
| 2023/01/17 | 3,220 | 3,236 | 3,191 | 3,215 | -11 | -0.3% | 1,550,600 |
| 2023/01/16 | 3,210 | 3,233 | 3,193 | 3,226 | +5 | +0.2% | 1,827,000 |
| 2023/01/13 | 3,264 | 3,290 | 3,221 | 3,221 | -63 | -1.9% | 2,789,200 |
| 2023/01/12 | 3,279 | 3,294 | 3,262 | 3,284 | -17 | -0.5% | 2,223,900 |
| 2023/01/11 | 3,316 | 3,324 | 3,278 | 3,301 | -6 | -0.2% | 2,337,000 |
| 2023/01/10 | 3,325 | 3,338 | 3,289 | 3,307 | -1 | ±0% | 2,234,500 |
| 2023/01/06 | 3,303 | 3,335 | 3,292 | 3,308 | +9 | +0.3% | 1,970,100 |
| 2023/01/05 | 3,325 | 3,339 | 3,297 | 3,299 | -1 | ±0% | 1,766,400 |
| 2023/01/04 | 3,358 | 3,358 | 3,300 | 3,300 | -68 | -2% | 2,349,700 |
| 2022/12/30 | 3,421 | 3,426 | 3,359 | 3,368 | -34 | -1% | 1,784,800 |
| 2022/12/29 | 3,378 | 3,403 | 3,358 | 3,402 | -30 | -0.9% | 1,634,200 |
| 2022/12/28 | 3,429 | 3,455 | 3,419 | 3,432 | -17 | -0.5% | 1,603,800 |
| 2022/12/27 | 3,429 | 3,467 | 3,421 | 3,449 | +32 | +0.9% | 1,456,900 |
| 2022/12/26 | 3,440 | 3,457 | 3,395 | 3,417 | -26 | -0.8% | 904,300 |
| 2022/12/23 | 3,422 | 3,454 | 3,414 | 3,443 | -4 | -0.1% | 1,172,800 |
| 2022/12/22 | 3,449 | 3,450 | 3,413 | 3,447 | +22 | +0.6% | 1,320,600 |
| 2022/12/21 | 3,452 | 3,469 | 3,415 | 3,425 | -27 | -0.8% | 1,972,800 |
| 2022/12/20 | 3,543 | 3,574 | 3,417 | 3,452 | -91 | -2.6% | 2,271,500 |
| 2022/12/19 | 3,543 | 3,580 | 3,537 | 3,543 | -18 | -0.5% | 1,590,700 |
| 2022/12/16 | 3,547 | 3,582 | 3,525 | 3,561 | -13 | -0.4% | 2,480,100 |
| 2022/12/15 | 3,615 | 3,632 | 3,566 | 3,574 | -75 | -2.1% | 2,085,600 |
| 2022/12/14 | 3,629 | 3,659 | 3,587 | 3,649 | +30 | +0.8% | 1,798,000 |
| 2022/12/13 | 3,636 | 3,659 | 3,609 | 3,619 | +5 | +0.1% | 982,400 |
| 2022/12/12 | 3,598 | 3,637 | 3,596 | 3,614 | -19 | -0.5% | 1,333,300 |
| 2022/12/09 | 3,547 | 3,648 | 3,547 | 3,633 | +26 | +0.7% | 2,484,300 |
| 2022/12/08 | 3,670 | 3,670 | 3,579 | 3,607 | -43 | -1.2% | 1,776,300 |
| 2022/12/07 | 3,638 | 3,662 | 3,630 | 3,650 | +3 | +0.1% | 1,874,700 |
| 2022/12/06 | 3,607 | 3,665 | 3,603 | 3,647 | +37 | +1% | 2,021,500 |
| 2022/12/05 | 3,587 | 3,610 | 3,558 | 3,610 | +40 | +1.1% | 1,563,800 |
| 2022/12/02 | 3,621 | 3,624 | 3,547 | 3,570 | -86 | -2.4% | 2,253,100 |
| 2022/12/01 | 3,685 | 3,714 | 3,641 | 3,656 | +32 | +0.9% | 2,166,200 |
| 2022/11/30 | 3,603 | 3,653 | 3,591 | 3,624 | -24 | -0.7% | 4,878,900 |
| 2022/11/29 | 3,625 | 3,666 | 3,603 | 3,648 | -7 | -0.2% | 1,853,700 |
| 2022/11/28 | 3,649 | 3,664 | 3,623 | 3,655 | +24 | +0.7% | 1,983,900 |
| 2022/11/25 | 3,673 | 3,690 | 3,614 | 3,631 | -29 | -0.8% | 1,555,800 |
| 2022/11/24 | 3,634 | 3,681 | 3,627 | 3,660 | +56 | +1.6% | 2,791,000 |
| 2022/11/22 | 3,555 | 3,604 | 3,555 | 3,604 | +92 | +2.6% | 2,971,600 |
| 2022/11/21 | 3,467 | 3,520 | 3,464 | 3,512 | +38 | +1.1% | 2,613,200 |
551～
600
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 862,000円 | +1.7% | +5.0% | 2.90% | 34.60倍 | 7.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
